Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-92.22%
↑ 20% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-115.92%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -92.22% | -31.3% |
| 2024 | -70.22% | +41.9% |
| 2023 | -120.82% | +20.5% |
| 2022 | -152.03% | -31.4% |
| 2021 | -115.73% | -34.5% |
| 2020 | -86.04% | +0.6% |
| 2019 | -86.59% | +57.5% |
| 2018 | -203.72% | - |